These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18412600)

  • 21. A short term study of the additive effect of timolol and brimonidine on intraocular pressure.
    Arici MK; Sayici M; Toker M; Erdoğan H; Topalkara A
    Eye (Lond); 2002 Jan; 16(1):39-43. PubMed ID: 11913886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trial.
    Sherwood MB; Craven ER; Chou C; DuBiner HB; Batoosingh AL; Schiffman RM; Whitcup SM
    Arch Ophthalmol; 2006 Sep; 124(9):1230-8. PubMed ID: 16966616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fixed combinations of dorzolamide-timolol and brimonidine-timolol in the management of glaucoma.
    Razeghinejad MR; Sawchyn AK; Katz LJ
    Expert Opin Pharmacother; 2010 Apr; 11(6):959-68. PubMed ID: 20307220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.
    Nixon DR; Yan DB; Chartrand JP; Piemontesi RL; Simonyi S; Hollander DA
    Curr Med Res Opin; 2009 Jul; 25(7):1645-53. PubMed ID: 19476406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of brimonidine 0.2% as adjunctive therapy for patients with glaucoma inadequately controlled with otherwise maximal medical therapy.
    thoe Schwartzenberg GW; Buys YM
    Ophthalmology; 1999 Aug; 106(8):1616-20. PubMed ID: 10442912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of 24-hour intraocular pressure reduction obtained with brinzolamide/timolol or brimonidine/timolol fixed-combination adjunctive to travoprost therapy.
    Konstas AG; Holló G; Haidich AB; Mikropoulos DG; Giannopoulos T; Voudouragkaki IC; Paschalinou E; Konidaris V; Samples JR
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):652-7. PubMed ID: 23550916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The evolving pharmacotherapeutic profile of brimonidine, an alpha 2-adrenergic agonist, after four years of continuous use.
    Cantor LB
    Expert Opin Pharmacother; 2000 May; 1(4):815-34. PubMed ID: 11249518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contrast sensitivity improves after brimonidine therapy in primary open angle glaucoma: a case for neuroprotection.
    Evans DW; Hosking SL; Gherghel D; Bartlett JD
    Br J Ophthalmol; 2003 Dec; 87(12):1463-5. PubMed ID: 14660453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.
    Hatanaka M; Grigera DE; Barbosa WL; Jordao M; Susanna R
    J Glaucoma; 2008 Dec; 17(8):674-9. PubMed ID: 19092465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Phase III clinical trial of brimonidine in patients with primary open-angle glaucoma and ocular hypertension--comparison of the effects of brimonidine monotherapy versus timolol monotherapy, or combination brimonidine/prostaglandins therapy versus combination placebo/prostaglandins therapy].
    Araie M; Yamazaki Y; Sugiyama K; Kuwayama Y; Tanihara H
    Nippon Ganka Gakkai Zasshi; 2012 Oct; 116(10):955-66. PubMed ID: 23285843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic beta-blocker therapy and brimonidine and timolol.
    Coulibaly R
    Ophthalmology; 2001 Aug; 108(8):1368. PubMed ID: 11470677
    [No Abstract]   [Full Text] [Related]  

  • 32. A double-masked randomized crossover study comparing the effect of latanoprost/timolol and brimonidine/timolol fixed combination on intraocular pressure and ocular blood flow in patients with primary open-angle glaucoma or ocular hypertension.
    Hommer A; Sperl P; Resch H; Popa-Cherecheanu A; Qiao C; Schmetterer L; Garhöfer G
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):569-75. PubMed ID: 22775229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meta-analysis of the effect of latanoprost and brimonidine on intraocular pressure in the treatment of glaucoma.
    Einarson TR; Kulin NA; Tingey D; Iskedjian M
    Clin Ther; 2000 Dec; 22(12):1502-15. PubMed ID: 11192141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A 3-month comparison of efficacy and safety of brimonidine-purite 0.15% and brimonidine 0.2% in patients with glaucoma or ocular hypertension.
    Mundorf T; Williams R; Whitcup S; Felix C; Batoosingh A
    J Ocul Pharmacol Ther; 2003 Feb; 19(1):37-44. PubMed ID: 12648302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brimonidine/Timolol: a viewpoint by Richard Fiscella.
    Fiscella R
    Drugs Aging; 2006; 23(9):762-3. PubMed ID: 17020400
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of the clinical success and quality-of-life impact of brimonidine 0.2% and betaxolol 0.25 % suspension in patients with elevated intraocular pressure.
    Cantor LB; Hoop J; Katz LJ; Flartey K;
    Clin Ther; 2001 Jul; 23(7):1032-9. PubMed ID: 11519768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The comparative ocular hypotensive effect of apraclonidine with timolol maleate in exfoliation versus primary open-angle glaucoma patients.
    Konstas AG; Maltezos A; Mantziris DA; Sine CS; Stewart WC
    Eye (Lond); 1999 Jun; 13 ( Pt 3a)():314-8. PubMed ID: 10624424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomised controlled trial comparing the effect of brimonidine and timolol on visual field loss after acute primary angle closure.
    Aung T; Oen FT; Wong HT; Chan YH; Khoo BK; Liu YP; Ho CL; See J; Thean LH; Viswanathan AC; Seah SK; Chew PT
    Br J Ophthalmol; 2004 Jan; 88(1):88-94. PubMed ID: 14693782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meta-analysis of α2-adrenergic agonists versus carbonic anhydrase inhibitors as adjunctive therapy.
    Cheng JW; Cheng SW; Yu DY; Wei RL; Lu GC
    Curr Med Res Opin; 2012 Apr; 28(4):543-50. PubMed ID: 22321008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of brimonidine and dorzolamide for intraocular pressure lowering in glaucoma and ocular hypertension.
    Katz LJ; Simmons ST; Craven ER
    Curr Med Res Opin; 2007 Dec; 23(12):2971-83. PubMed ID: 17949534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.